B. King, “Impact of Disease History on the Efficacy of Ritlecitinib (PF-06651600) in Patients With Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study”, J of Skin, vol. 6, no. 6, p. s101, Nov. 2022.